Marta Ježová

524 total citations
28 papers, 182 citations indexed

About

Marta Ježová is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Marta Ježová has authored 28 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Marta Ježová's work include Cancer Genomics and Diagnostics (3 papers), RNA modifications and cancer (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Marta Ježová is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), RNA modifications and cancer (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Marta Ježová collaborates with scholars based in Czechia, Slovakia and United States. Marta Ježová's co-authors include Jaroslav Štěrba, Renata Veselská, Ondřej Slabý, Michal Kýr, Petr Janků, Anna Seehofnerová, Elleni Michu, Jakub Neradil, Paweł Stankiewicz and Partha Sen and has published in prestigious journals such as PLoS ONE, Scientific Reports and BMC Cancer.

In The Last Decade

Marta Ježová

23 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Ježová Czechia 8 77 71 38 33 33 28 182
Benjamin Goode United States 4 85 1.1× 44 0.6× 39 1.0× 45 1.4× 22 0.7× 4 210
Danielle C. Costigan United States 9 52 0.7× 83 1.2× 48 1.3× 51 1.5× 18 0.5× 14 276
D. Zachar France 5 56 0.7× 64 0.9× 55 1.4× 59 1.8× 21 0.6× 13 157
Alessandra Merlini Italy 8 52 0.7× 100 1.4× 15 0.4× 83 2.5× 39 1.2× 34 209
Yoshiyuki Nagumo Japan 8 75 1.0× 64 0.9× 91 2.4× 35 1.1× 35 1.1× 48 238
Molly E. Heft Neal United States 8 51 0.7× 52 0.7× 53 1.4× 59 1.8× 19 0.6× 28 195
Nicolas Weinbreck France 12 56 0.7× 102 1.4× 35 0.9× 72 2.2× 66 2.0× 21 280
Vijetha Kumar United States 3 36 0.5× 95 1.3× 43 1.1× 49 1.5× 31 0.9× 6 210
Fumito Yamazaki Japan 6 41 0.5× 71 1.0× 14 0.4× 75 2.3× 32 1.0× 21 163
Lucile Delespaul France 7 41 0.5× 89 1.3× 28 0.7× 98 3.0× 40 1.2× 9 188

Countries citing papers authored by Marta Ježová

Since Specialization
Citations

This map shows the geographic impact of Marta Ježová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Ježová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Ježová more than expected).

Fields of papers citing papers by Marta Ježová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Ježová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Ježová. The network helps show where Marta Ježová may publish in the future.

Co-authorship network of co-authors of Marta Ježová

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Ježová. A scholar is included among the top collaborators of Marta Ježová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Ježová. Marta Ježová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ježová, Marta, et al.. (2025). Sacrococcygeal teratoma - prognosis based on prenatal ultrasound diagnosis, single-center experience and literature review. BMC Pregnancy and Childbirth. 25(1). 469–469.
2.
Slabá, Kateřina, Marta Ježová, Petra Pokorná, et al.. (2023). Two sisters with cardiac‐urogenital syndrome secondary to pathogenic splicing variant in the MYRF gene with unaffected parents: A case of gonadal mosaicism?. Molecular Genetics & Genomic Medicine. 11(5). e2139–e2139. 3 indexed citations
3.
Pokorná, Petra, Kristýna Nosková, Zdeněk Pavelka, et al.. (2023). Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors. Scientific Reports. 13(1). 21623–21623. 8 indexed citations
4.
5.
Pokorná, Petra, Giannoula Klement, Veronika Kanderová, et al.. (2022). Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing. JCO Precision Oncology. 6(6). e2100525–e2100525. 2 indexed citations
6.
Macháč, Josef, et al.. (2021). Salivary Gland Choristoma of the Middle Ear in a Child: A Case Report. Ear Nose & Throat Journal. 100(3_suppl). 356S–359S. 2 indexed citations
7.
Švajdler, Marián, Pavel Fabián, Leoš Křen, et al.. (2021). SDHC Methylation Pattern in Patients With Carney Triad. Applied immunohistochemistry & molecular morphology. 29(8). 599–605. 2 indexed citations
8.
Múdrý, Peter, et al.. (2021). Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis. Journal of bone oncology. 28. 100362–100362. 20 indexed citations
9.
Veselská, Renata, Marta Ježová, Michal Kýr, et al.. (2019). Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy. Frontiers in Oncology. 9. 1221–1221. 7 indexed citations
10.
Szafrański, Przemysław, Qian Liu, Justyna A. Karolak, et al.. (2019). Association of rare non-coding SNVs in the lung-specific FOXF1 enhancer with a mitigation of the lethal ACDMPV phenotype. Human Genetics. 138(11-12). 1301–1311. 16 indexed citations
11.
Kýr, Michal, Jakub Neradil, Marta Ježová, et al.. (2019). Individualization of Treatment Improves the Survival of Children With High-Risk Solid Tumors: Comparative Patient Series Analysis in a Real-Life Scenario. Frontiers in Oncology. 9. 644–644. 1 indexed citations
12.
Chlapek, Petr, et al.. (2019). Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers. PLoS ONE. 14(6). e0218269–e0218269. 10 indexed citations
13.
Ježová, Marta & Renata Gaillyová. (2019). Familial hemophagocytic lymphohistiocytosis: from autopsy to prenatal diagnosis. Report of a case.. PubMed. 53(1). 29–34. 1 indexed citations
14.
15.
Adam, Zdeněk, Marta Ježová, Pavel Šlampa, et al.. (2017). Indeterminate cell histiocytosis - disappearance of skin infiltration following electron beam therapy and an application of 2-chlorodeoxyadenosine: case report. Vnitřní lékařství. 63(4). 284–288.
16.
Mikulášová, Aneta, Zdeněk Pavelka, Marta Ježová, et al.. (2016). Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant. Klinicka onkologie. 29(Suppl 1). S83–S88. 2 indexed citations
17.
Sen, Partha, Petr Janků, Marta Ježová, et al.. (2012). A familial case of alveolar capillary dysplasia with misalignment of pulmonary veins supports paternal imprinting of FOXF1 in human. European Journal of Human Genetics. 21(4). 474–477. 34 indexed citations
18.
Kolena, J, et al.. (2009). Involvement of tryptophan in the structural alterations of the rat ovarian LH/hCG receptor. Experimental and Clinical Endocrinology & Diabetes. 105(5). 304–307.
19.
Ježová, Marta, et al.. (2008). Hypertext atlas of fetal and neonatal pathology. Diagnostic Pathology. 3(Suppl 1). S9–S9. 1 indexed citations
20.
Kolena, J, Soňa Scsuková, & Marta Ježová. (2002). Thermal destabilization of ovarian LH/hCG receptors by negatively charged lipids. Experimental and Clinical Endocrinology & Diabetes. 110(2). 77–79. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Goode Breakdown of academic impact, for papers by Danielle C. Costigan Breakdown of academic impact, for papers by D. Zachar Breakdown of academic impact, for papers by Alessandra Merlini Breakdown of academic impact, for papers by Yoshiyuki Nagumo Breakdown of academic impact, for papers by Molly E. Heft Neal Breakdown of academic impact, for papers by Nicolas Weinbreck Breakdown of academic impact, for papers by Vijetha Kumar Breakdown of academic impact, for papers by Fumito Yamazaki Breakdown of academic impact, for papers by Lucile Delespaul
Rankless by CCL
2026